Teva Pharmaceutical Industries Ltd. ADR (TEVA)

Teva Pharmaceutical Industries operates as a generic pharmaceutical company worldwide. It develops, manufactures, and markets generic and human pharmaceuticals, and active pharmaceutical ingredients, as well as animal health pharmaceutical products. It is a top 15 global pharmaceutical company, with USD18.3 billion in sales in 2011, has a direct presence in 60 countries and product distribution in over 120 countries, employing 46,000 with 6,000 in Quality Assurance and Quality Control and manufactured 71 Billion tablets in 2011.

Note:  From the November 2015 dividend onwards dividends are declared in US Dollars. However dividends prior to November 2015 were declared in Israeli New Shekel, each amount being converted to US Dollars at an appropriate rate, however since the actual rate is not known some differences occured.

Note: December 14, 2017 Teva Announces Restructuring Plan and Additional Measures to Improve Its Business and Financial Performance: -
The company will immediately suspend dividends on ordinary shares and ADSs, while dividends on mandatory convertible preferred shares will be evaluated on a quarterly basis per current practice.